Navega Therapeutics, Inc. — Form D
Navega Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-30. The offering totals $2.5M, of which $1.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-01-30
- Form: D
- Accession: 0002107977-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $1.3M
- Remaining: $1.2M
- Investors: 8
- Date of first sale: 2026-01-02
- Revenue range: Decline to Disclose
- SEC file number: 021-571986
Issuer
- Name: Navega Therapeutics, Inc.
- CIK: 0002107977
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3210 MERRYFIELD ROW, SAN DIEGO, CA, 92121
- Phone: 858-242-1578
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Fernando Aleman | Director | San Diego, CA |
| Ana Moreno | Director | San Diego, CA |
| Fernando Aleman | Executive Officer | San Diego, CA |
| Ana Moreno | Executive Officer | San Diego, CA |
| Randy Socol | Executive Officer | San Diego, CA |
More